• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于分子模拟的高活性天然产物研究以阻断 SARS-CoV-2 的 nsp10-nsp16 复合物的形成。

Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.

机构信息

Department of Biochemistry and Molecular Biology 1, Dasman Diabetes Institute, Dasman 15462, Kuwait.

Department of Genetics and Bioinformatics 2, Dasman Diabetes Institute, Dasman 15462, Kuwait.

出版信息

Biomolecules. 2021 Apr 14;11(4):573. doi: 10.3390/biom11040573.

DOI:10.3390/biom11040573
PMID:33919870
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8070809/
Abstract

The SARS-CoV-2 non-structural protein (nsp) nsp10-nsp16 complex is essential for the 2'-O-methylation of viral mRNA, a crucial step for evading the innate immune system, and it is an essential process in SARS-CoV-2 life cycle. Therefore, detecting molecules that can disrupt the nsp10-nsp16 interaction are prospective antiviral drugs. In this study, we screened the North African Natural Products database (NANPDB) for molecules that can interact with the nsp10 interface and disturb the nsp10-nsp16 complex formation. Following rigorous screening and validation steps, in addition to toxic side effects, drug interactions and a risk /benefit assessment, we identified four compounds (genkwanin-6-C-beta-glucopyranoside, paraliane diterpene, 4,5-di-p-trans-coumaroylquinic acid and citrinamide A) that showed the best binding affinity and most favourable interaction with nsp10 interface residues. To understand the conformational stability and dynamic features of nsp10 bound to the four selected compounds, we subjected each complex to 200 ns molecular dynamics simulations. We then calculated the free binding energies of compounds interacting with nsp10 structure using the molecular mechanics-generalised Born surface area (MMGBSA). Of the four compounds, genkwanin-6-C-beta-glucopyranoside demonstrated the most stable complex with nsp10, in addition to a tighter binding affinity of -37.4 ± 1.3 Kcal/mol. This potential to disrupt the nsp10-nsp16 interface interaction and inhibit it now sets the path for functional studies.

摘要

SARS-CoV-2 的非结构蛋白(nsp)nsp10-nsp16 复合物是病毒 mRNA 2'-O-甲基化所必需的,这是逃避先天免疫系统的关键步骤,也是 SARS-CoV-2 生命周期中的一个重要过程。因此,检测能够破坏 nsp10-nsp16 相互作用的分子是有前途的抗病毒药物。在这项研究中,我们筛选了北非天然产物数据库(NANPDB),以寻找能够与 nsp10 界面相互作用并干扰 nsp10-nsp16 复合物形成的分子。经过严格的筛选和验证步骤,除了毒性副作用、药物相互作用和风险/收益评估外,我们确定了四种化合物(根皮苷-6-C-β-吡喃葡萄糖苷、 paraliane 二萜、4,5-二-p-反式-肉桂酰奎宁酸和 citrinamide A),它们与 nsp10 界面残基具有最佳的结合亲和力和最有利的相互作用。为了了解与四种选定化合物结合的 nsp10 的构象稳定性和动态特征,我们对每个复合物进行了 200 ns 的分子动力学模拟。然后,我们使用分子力学-广义 Born 表面积(MMGBSA)计算了与 nsp10 结构相互作用的化合物的自由结合能。在这四种化合物中,根皮苷-6-C-β-吡喃葡萄糖苷与 nsp10 形成的复合物最稳定,结合亲和力也更强,为-37.4±1.3 Kcal/mol。这种破坏 nsp10-nsp16 界面相互作用并抑制其的潜力为功能研究开辟了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8070809/91787039a93a/biomolecules-11-00573-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8070809/51b0c07e1571/biomolecules-11-00573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8070809/c350d4c13136/biomolecules-11-00573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8070809/4120412d611c/biomolecules-11-00573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8070809/91787039a93a/biomolecules-11-00573-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8070809/51b0c07e1571/biomolecules-11-00573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8070809/c350d4c13136/biomolecules-11-00573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8070809/4120412d611c/biomolecules-11-00573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8070809/91787039a93a/biomolecules-11-00573-g004.jpg

相似文献

1
Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.基于分子模拟的高活性天然产物研究以阻断 SARS-CoV-2 的 nsp10-nsp16 复合物的形成。
Biomolecules. 2021 Apr 14;11(4):573. doi: 10.3390/biom11040573.
2
A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19.一种用于筛选SARS-CoV-2 nsp10-nsp16复合物以开发COVID-19治疗药物的高通量RNA置换测定法。
SLAS Discov. 2021 Jun;26(5):620-627. doi: 10.1177/2472555220985040. Epub 2021 Jan 10.
3
A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex.一种高通量基于放射性的 SARS-CoV-2 nsp10-nsp16 复合物筛选方法。
SLAS Discov. 2021 Jul;26(6):757-765. doi: 10.1177/24725552211008863. Epub 2021 Apr 19.
4
Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的NSP10/NSP16甲基转移酶和主要蛋白酶的抗病毒、抗蛋白酶和抗感染化合物的虚拟筛选、药物代谢动力学/药物毒性(ADME/T)及结合自由能分析
J Recept Signal Transduct Res. 2020 Dec;40(6):605-612. doi: 10.1080/10799893.2020.1772298. Epub 2020 Jun 1.
5
Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.鉴定萘啶和喹啉衍生物作为潜在的 Nsp16-Nsp10 抑制剂:基于计算药理学的研究。
J Biomol Struct Dyn. 2022 Jun;40(9):3899-3906. doi: 10.1080/07391102.2020.1851305. Epub 2020 Nov 30.
6
Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10.基于虚拟筛选和分子动力学模拟鉴定靶向 SARS-CoV-2 NSP10 的天然抗病毒药物
Biochem Biophys Res Commun. 2022 Oct 20;626:114-120. doi: 10.1016/j.bbrc.2022.08.029. Epub 2022 Aug 14.
7
Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2'--Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs.基于配体和结构的计算机筛选,从 3009 种 FDA 批准药物中确定最有希望的 SARS-CoV-2 nsp16-nsp10 2'-甲基转移酶复合物抑制剂。
Molecules. 2022 Mar 31;27(7):2287. doi: 10.3390/molecules27072287.
8
Structural and functional insights into the 2'-O-methyltransferase of SARS-CoV-2.对 SARS-CoV-2 2'-O-甲基转移酶的结构和功能的深入了解。
Virol Sin. 2024 Aug;39(4):619-631. doi: 10.1016/j.virs.2024.07.001. Epub 2024 Jul 3.
9
Identification and Inhibition of the Druggable Allosteric Site of SARS-CoV-2 NSP10/NSP16 Methyltransferase through Computational Approaches.通过计算方法鉴定和抑制 SARS-CoV-2 NSP10/NSP16 甲基转移酶的变构结合位点
Molecules. 2022 Aug 17;27(16):5241. doi: 10.3390/molecules27165241.
10
Cheminformatics approach to identify andrographolide derivatives as dual inhibitors of methyltransferases (nsp14 and nsp16) of SARS-CoV-2.化学信息学方法鉴定穿心莲内酯衍生物作为 SARS-CoV-2 的甲基转移酶(nsp14 和 nsp16)双重抑制剂。
Sci Rep. 2024 Apr 29;14(1):9801. doi: 10.1038/s41598-024-58532-7.

引用本文的文献

1
Rare taxa as the major drivers of the secondary metabolite accumulation in Rheum tanguticum.珍稀类群作为唐古特大黄次生代谢产物积累的主要驱动因素。
BMC Plant Biol. 2025 Jul 30;25(1):983. doi: 10.1186/s12870-025-07068-7.
2
Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16.基于结构的 SARS-CoV-2 nsp14 和 nsp16 甲基转移酶抑制剂虚拟筛选。
Molecules. 2024 May 15;29(10):2312. doi: 10.3390/molecules29102312.
3
CuO nanoparticles for green synthesis of significant anti-Helicobacter pylori compounds with in silico studies.

本文引用的文献

1
In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro).山奈酚作为严重急性呼吸综合征冠状病毒2主蛋白酶(3CLpro)潜在抑制剂的计算机模拟和体外评估
Phytother Res. 2021 Jun;35(6):2841-2845. doi: 10.1002/ptr.6998. Epub 2021 Jan 15.
2
Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM.与辅因子S-腺苷甲硫氨酸(SAM)结合的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)甲基转移酶刺激因子异二聚体nsp16/nsp10结构动力学的计算研究
Front Mol Biosci. 2020 Nov 24;7:590165. doi: 10.3389/fmolb.2020.590165. eCollection 2020.
3
氧化铜纳米粒子用于绿色合成具有抗幽门螺杆菌活性的化合物:基于计算机模拟的研究。
Sci Rep. 2024 Jan 18;14(1):1608. doi: 10.1038/s41598-024-51708-1.
4
The regulation of antiviral innate immunity through non-mA RNA modifications.通过非 mRNA 修饰调控抗病毒先天免疫
Front Immunol. 2023 Oct 17;14:1286820. doi: 10.3389/fimmu.2023.1286820. eCollection 2023.
5
Targeting SARS-CoV-2 Macrodomain-1 to Restore the Innate Immune Response Using In Silico Screening of Medicinal Compounds and Free Energy Calculation Approaches.利用药物化合物的计算机模拟筛选和自由能计算方法靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的Macrodomain-1以恢复先天免疫反应
Viruses. 2023 Sep 12;15(9):1907. doi: 10.3390/v15091907.
6
A Non-Structural Protein of Severe Acute Respiratory Syndrome Coronavirus 2 with a Potential Ability to Reduce Blood Glucose for Use in Controlling Type 2 Diabetes Mellitus.严重急性呼吸综合征冠状病毒 2 的一种非结构蛋白,具有降低血糖的潜在能力,可用于控制 2 型糖尿病。
Arch Razi Inst. 2022 Dec 31;77(6):2181-2186. doi: 10.22092/ARI.2022.358070.2145. eCollection 2022 Dec.
7
Phenolic compounds versus SARS-CoV-2: An update on the main findings against COVID-19.酚类化合物与严重急性呼吸综合征冠状病毒2:抗2019冠状病毒病主要研究结果的最新进展
Heliyon. 2022 Sep 20;8(9):e10702. doi: 10.1016/j.heliyon.2022.e10702. eCollection 2022 Sep.
8
Discovery of natural products to block SARS-CoV-2 S-protein interaction with Neuropilin-1 receptor: A molecular dynamics simulation approach.利用分子动力学模拟方法发现阻断 SARS-CoV-2 S 蛋白与 Neuropilin-1 受体相互作用的天然产物。
Microb Pathog. 2022 Sep;170:105701. doi: 10.1016/j.micpath.2022.105701. Epub 2022 Aug 10.
9
Novel Inhibitors of 2'--Methyltransferase of the SARS-CoV-2 Coronavirus.新型 SARS-CoV-2 冠状病毒 2′-甲基转移酶抑制剂。
Molecules. 2022 Apr 23;27(9):2721. doi: 10.3390/molecules27092721.
10
The dolabellane diterpenes as potential inhibitors of the SARS-CoV-2 main protease: molecular insight of the inhibitory mechanism through computational studies.多拉贝烷二萜类化合物作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶的潜在抑制剂:通过计算研究对抑制机制的分子洞察
RSC Adv. 2021 Dec 10;11(62):39455-39466. doi: 10.1039/d1ra07584e. eCollection 2021 Dec 6.
Crystal Structure of Non-Structural Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2.
严重急性呼吸综合征冠状病毒 2 非结构蛋白 10 的晶体结构
Int J Mol Sci. 2020 Oct 6;21(19):7375. doi: 10.3390/ijms21197375.
4
Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus.结构分析、虚拟筛选和分子模拟鉴定靶向 SARS-CoV-2 冠状病毒 2'-O-核糖甲基转移酶的潜在抑制剂。
J Biomol Struct Dyn. 2022 Feb;40(3):1331-1346. doi: 10.1080/07391102.2020.1828172. Epub 2020 Oct 4.
5
High-resolution structures of the SARS-CoV-2 2'--methyltransferase reveal strategies for structure-based inhibitor design.SARS-CoV-2 2'-甲基转移酶的高分辨率结构揭示了基于结构的抑制剂设计策略。
Sci Signal. 2020 Sep 29;13(651):eabe1202. doi: 10.1126/scisignal.abe1202.
6
Pharmacoinformatic Investigation of Medicinal Plants from East Africa.东非药用植物的药物信息学研究。
Mol Inform. 2020 Nov;39(11):e2000163. doi: 10.1002/minf.202000163. Epub 2020 Oct 8.
7
Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein.严重急性呼吸综合征冠状病毒2核衣壳磷蛋白N端RNA结合结构域识别RNA机制的结构见解
Comput Struct Biotechnol J. 2020;18:2174-2184. doi: 10.1016/j.csbj.2020.08.006. Epub 2020 Aug 12.
8
Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白10/非结构蛋白16 2'-O-甲基转移酶的晶体结构及其对抗病毒药物设计的意义
Signal Transduct Target Ther. 2020 Jul 29;5(1):131. doi: 10.1038/s41392-020-00241-4.
9
Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.SARS-CoV-2 甲基转移酶复合物结构分析,复合物与 sinefungin 结合参与 RNA 帽结构生成。
Nat Commun. 2020 Jul 24;11(1):3717. doi: 10.1038/s41467-020-17495-9.
10
Structural basis of RNA cap modification by SARS-CoV-2.SARS-CoV-2 对 RNA 帽修饰的结构基础。
Nat Commun. 2020 Jul 24;11(1):3718. doi: 10.1038/s41467-020-17496-8.